Sandu Pharmaceuticals, Inc — Quarterly Results & Earnings

₹30.52

-6.58%

Profit Growth YoY4.00%Latest quarter

Sales Growth YoY-0.45%Latest quarter

Sales CAGR 5Y6.79%5 year compound

Profit CAGR 5Y16.57%5 year compound

📋

Quarterly Performance

YoY Profit Growth+4.00%

📈 Moderate growth

YoY Sales Growth-0.45%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

3.88%

EPS Growth 5Y

9.55%

Interest Coverage

Higher = safer debt servicing

19.25

ROE

3.75%

ROCE

5.47%

💡

Growth Analysis

Sandu Pharmaceuticals, Inc reported YoY profit growth of 4.00% and revenue growth of -0.45% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 6.79% and profits at 16.57% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Sandu Pharmaceuticals, Inc

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.